Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
Lee
H A
HA
Renal Unit, St Mary's Hospital, Portsmouth, United Kingdom.
Slapak
M
M
Raman
G V
GV
Mason
J C
JC
Digard
N
N
Wise
M
M
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D002102:Cadaver; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D012263:Ribonucleosides / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine